Regulatory requirements for a vitamin C and ferulic acid eye serum depend on your target market: in the United States, the product is classified as a cosmetic (not a drug) and must comply with FDA cosmetic labeling rules and the Fair Packaging and Labeling Act; in the European Union, it must be notified via the CPNP (Cosmetic Products Notification Portal) and comply with the Cosmetics Regulation (EC 1223/2009); in Canada, it is a cosmetic under the Natural and Non-prescription Health Products Directorate (NNHPD) and requires a license; in Australia, it is regulated by the TGA (Therapeutic Goods Administration) and may be classified as a cosmetic or therapeutic good depending on claims made. The single most important step is to ensure your claims (e.g., "reduces dark circles," "brightens the eye area," "minimizes fine lines") do not cross into drug territory, because a drug claim (e.g., "treats age spots," "cures wrinkles," "reverses skin damage") triggers a far more stringent approval process and usually requires clinical efficacy data.
In the United States, cosmetics are regulated by the FDA under the Food, Drug, and Cosmetic Act (FD&C Act) and must declare all ingredients in order of descending concentration using INCI (International Nomenclature of Cosmetic Ingredients) names on the label. The ingredient list is mandatory and must be in English. L-ascorbic acid is listed as "Ascorbic Acid" on US labels; ferulic acid is "Ferulic Acid"; vitamin E (tocopherol) is "Tocopherol"; magnesium ascorbyl phosphate is "Magnesium Ascorbyl Phosphate." The US does not require pre-market approval of cosmetics, and there is no federal cosmetic license requirement; however, you must register your manufacturing facility with the FDA and report serious adverse events (allergen reactions, chemical burns) to the FDA's MedWatch system. If your product is manufactured overseas, the importer (typically you, if you're the brand owner) bears responsibility for ensuring the product complies with US law. You are not required to provide stability data to the FDA at the time of sale, but you must have it on file in case of a recall or investigation, and you should maintain batch records and shelf-life dating. A common legal requirement is a "Caution" or "Use" statement if the product is positioned for the eye area; many brands include "For external use only" or "Discontinue use if irritation occurs" to protect against liability.
In the European Union, a vitamin C and ferulic acid eye serum is a cosmetic under the Cosmetics Regulation (EC 1223/2009) and must be notified in the CPNP before it is placed on the market. The CPNP notification requires a comprehensive dossier including: the product name, intended use, INCI ingredient list with exact percentages, manufacturing process (in brief), stability data (supporting that the product remains safe and effective over its declared shelf life), and a safety assessment conducted by a qualified person (usually a cosmetic chemist or toxicologist). The EU also maintains a banned-substance list (Annex II, containing over 1,300 prohibited ingredients); your formulator must verify that every ingredient is either approved for cosmetics use or is not listed as banned. Preservatives in the EU are restricted to Annex V of the Cosmetics Regulation; commonly used US preservatives like methylisothiazolinone (MI) are approved in the EU but at lower concentration limits. If your product is manufactured outside the EU and imported, you must appoint a "responsible person" (a natural or legal person established in the EU) who acts as the importer and assumes regulatory responsibility. Stability data must demonstrate shelf life at room temperature (typically 25 °C / 60% RH) for a minimum of 3 years; accelerated testing (e.g., 40 °C / 75% RH for 8–12 weeks) is accepted as supportive evidence if real-time data are not yet complete.
In Canada, vitamin C and ferulic acid eye serums are cosmetics under the Natural and Non-prescription Health Products Directorate (NNHPD), and cosmetic manufacturers and importers must hold a cosmetic license issued by Health Canada's Product Licensing Division (PLD). The license application requires a product dossier with ingredient information, manufacturing site details, and stability/safety data; Canada also maintains a restricted and prohibited list of cosmetic ingredients. As with the EU, any claim suggesting a therapeutic effect (e.g., "treats wrinkles," "reverses aging") converts the product into a drug, which requires a Drug Identification Number (DIN) and clinical efficacy data. Australia's TGA similarly requires notification of cosmetics and maintains a list of prohibited and restricted substances; if your serum makes any therapeutic claim (even "reduces the appearance of fine lines" can be borderline), the TGA may classify it as a therapeutic good, which triggers a more complex approval pathway. Australia and New Zealand (which follows similar rules via NZGA) also require stability data supporting the claimed shelf life.
A critical regulatory distinction is whether your product is classified as a "leave-on" or "rinse-off" product. An eye serum is a leave-on product (worn on skin for extended periods), which imposes stricter microbiological standards (preservation efficacy, absence of pathogenic bacteria and fungi) compared to a rinse-off product like a facial wash. Most co-packers conduct a "challenge test" (also called preservative efficacy testing) on leave-on products, inoculating the serum with known bacteria and fungi to verify that the preservative system can inhibit microbial growth over the product's shelf life. This testing is expensive ($800–$1,500 per formulation) and mandatory in the EU and Canada; in the US, it is not legally required but is strongly recommended and expected by professional standards (set by organizations like the Personal Care Products Council).
Vitamin C serums carry a specific regulatory and liability consideration: the acidic pH required to stabilize L-ascorbic acid (pH 2.5–3.5) can irritate the eye area and sensitive skin. Many brands include a cautionary statement on the label, such as "Not recommended for sensitive skin" or "If irritation occurs, discontinue use." The US does not mandate this, but it reduces liability risk. The EU Cosmetics Regulation requires a safety assessment that accounts for the target population (are you marketing to all ages, or only adults 18+?) and the likely use pattern (applying around the eye area nightly). If your formulation uses a stabilized derivative instead (magnesium ascorbyl phosphate at neutral pH), the irritation risk profile is lower and regulatory language can be softer.
When working with a private label manufacturer on the AJ Cosmo Labs app, ask them to confirm that their proposed formula complies with the regulations of your target market. Many co-packers have boilerplate formulations that meet US and EU standards; if you're entering a new market (e.g., Australia, Japan, South Korea), verify that the ingredients and concentrations are approved in that jurisdiction. Request that your manufacturer or a regulatory consultant provide or review the safety assessment and CPNP notification (if applicable) before you launch. Many indie brands make the mistake of assuming their US-compliant product is automatically EU-compliant; in reality, ingredient restrictions and stability requirements often differ, and you may need to reformulate or provide additional stability data. Budget $500–$2,000 for regulatory review and dossier preparation, and 4–6 weeks for CPNP notification or Health Canada licensing if you're entering those markets for the first time.
Ingredients in this answer: Ferulic Acid · Ascorbic Acid · Tocopherol
Read the full guide on Private Label Vitamin C & Ferulic Acid Eye Serum Manufacturer →